ArticleTranslational lung cancer research2022

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study.

Huiping Qiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.